oxybutynin has been researched along with Lower Urinary Tract Symptom in 6 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The first-line drug treatment for lower urinary tract symptoms, orally administered antimuscarinics, fails to reach the equilibrium dissociation constant of muscarinic receptors even at their maximum plasma concentration and tends to evoke a half-maximal response at a muscarinic receptor occupancy of just 0." | 3.01 | Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options. ( Beckel, J; Chancellor, M; Chermansky, C; Cho, KJ; Ganguly, A; Hashimoto, M; Kanai, A; Kaufman, J; Tyagi, P; Tyagi, S; Yoshimura, N, 2023) |
| "The patients who had lower urinary tract symptoms (LUTS) were classified as nonmonosymptomatic NE (NMNE)." | 2.87 | The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial. ( Bayar, G; Kilinc, MF; Sariogullari, U; Yavuz, A, 2018) |
| "Williams-Beuren syndrome is a chromosomal disorder caused by a deletion at region 7q11." | 1.62 | Longitudinal Improvement of Lower Urinary Tract Symptoms in Williams-Beuren Syndrome. ( Bruschini, H; de Bessa, J; Gomes, CM; Hisano, M; Nahas, WC; Sammour, ZM; Srougi, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ganguly, A | 1 |
| Tyagi, S | 1 |
| Chermansky, C | 1 |
| Kanai, A | 1 |
| Beckel, J | 1 |
| Hashimoto, M | 1 |
| Cho, KJ | 1 |
| Chancellor, M | 1 |
| Kaufman, J | 1 |
| Yoshimura, N | 1 |
| Tyagi, P | 1 |
| Sammour, ZM | 1 |
| Hisano, M | 1 |
| de Bessa, J | 1 |
| Bruschini, H | 1 |
| Nahas, WC | 1 |
| Srougi, M | 1 |
| Gomes, CM | 1 |
| Schaeffer, EM | 1 |
| Yavuz, A | 1 |
| Bayar, G | 1 |
| Kilinc, MF | 1 |
| Sariogullari, U | 1 |
| Hakimi, Z | 1 |
| Johnson, M | 1 |
| Nazir, J | 1 |
| Blak, B | 1 |
| Odeyemi, IA | 1 |
| Osman, NI | 1 |
| Chapple, CR | 1 |
1 review available for oxybutynin and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options.
Topics: Administration, Intravesical; Aged; Botulinum Toxins, Type A; Drug-Related Side Effects and Adverse | 2023 |
1 trial available for oxybutynin and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial.
Topics: Antidiuretic Agents; Child; Deamino Arginine Vasopressin; Female; Humans; Lower Urinary Tract Sympto | 2018 |
4 other studies available for oxybutynin and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Longitudinal Improvement of Lower Urinary Tract Symptoms in Williams-Beuren Syndrome.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Child; Doxazosin; Female; Follow-Up Studies; Hu | 2021 |
Re: Efficacy of Tamsulosin, Oxybutynin, and Their Combination in the Control of Double-J Stent-Related Lower Urinary Tract Symptoms.
Topics: Humans; Lower Urinary Tract Symptoms; Mandelic Acids; Stents; Tamsulosin | 2018 |
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Human | 2015 |
Lower urinary tract symptoms revisited.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Benzhydryl Compounds; Cresols; Cystitis, Inter | 2012 |